Haleon plc (HLNCF)
| Market Cap | 42.50B |
| Revenue (ttm) | 15.07B |
| Net Income (ttm) | 1.62B |
| Shares Out | n/a |
| EPS (ttm) | 0.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.03 (0.54%) |
| Ex-Dividend Date | Aug 15, 2024 |
| Volume | 72,486 |
| Open | 4.550 |
| Previous Close | 4.635 |
| Day's Range | 4.550 - 4.550 |
| 52-Week Range | 3.900 - 5.360 |
| Beta | 0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 27, 2025 |
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops,... [Read more]
Full Company ProfileFinancial Performance
In 2023, Haleon's revenue was 11.30 billion, an increase of 4.09% compared to the previous year's 10.86 billion. Earnings were 1.05 billion, a decrease of -1.04%.
Financial numbers in GBP Financial StatementsNews
Haleon Partners with WPP to Launch ‘HealthNxt’ initiative to Transform Health Conversations in India
Through the commitment of #HealthInMoreHands, Haleon aims to democratize healthcare in India, empowering individuals to take control of their health. NEW DELHI, Nov. 20, 2024 /PRNewswire/ — Haleon (fo...
Dividend Income: Lanny's October 2024 Summary
Big Oil with BHP Billiton came big with a massive dividend. Canadian Imperial, one of the big 6 Canadian banks, sent a massive $210 dividend my way. There are a few less names now in 2024 than 2023, s...
Eminence Capital buys Gitlab, Charles River, exits Haleon, others in Q3
Eminence Capital added new positions in Gitlab, Charles River, Okta, and Atmus Filtration while exiting stakes in Haleon, Wix.com, Prologis, and GoDaddy in...
Haleon Selects Vistar Media as Preferred Global Partner for Programmatic Out-of-Home (OOH) Advertising
Vistar Media's programmatic OOH technology to enhance Haleon's premium, global media strategy Vistar Media's programmatic OOH technology to enhance Haleon's premium, global media strategy
Haleon plc (HLN) Q3 2024 Sales Call Transcript
Haleon CEO Brian McNamara: We've seen double-digit growth in China
Haleon CEO Brian McNamara joins 'Mad Money' host Jim Cramer to talk quarterly results, China growth, consumer trends and more.
Revenues fall at Sensodyne maker Haleon after weaker painkiller sales
Shares were lower in early trading on Thursday as a result.
Haleon reports marginal decline in third-quarter revenue
Haleon reported a marginal fall in its third-quarter revenue on Thursday, hurt by declines in its pain relief and digestive health segments.
Is the Haleon share price in trouble ahead of earnings?
Haleon (HLN) share price has retreated in the past few weeks, erasing some of the gains made earlier this year. Its London stock dropped to 375p, its lowest point since August 29, while its American A...
Haleon: Too Vanilla For My Liking - I See Why GSK & Pfizer Wanted Out
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock and why I recommend a sell rating.
Haleon: Tailwinds Are Mostly Priced In
Tombras Acquires New York Agency The Burns Group
Global independent agency Tombras has acquired The Burns Group, an independent advertising agency based in New York. The acquisition further bolsters Tombras' capabilities with top CPG clients, includ...
Pfizer sells further shares in Sensodyne maker Haleon for £2.4bn
Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out and floated in 2022.
Pfizer cuts Haleon stake in $3.3B share sale
Pfizer (PFE) reduces its stake in Haleon to 15% from 22.6% by selling £2.45B worth of shares, continuing its gradual divestment strategy. Read more here.
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
Pfizer Inc. (NYSE: PFE) has divested a $3.3 billion stake in Haleon (NYSE: HLN), reducing its holding in the British consumer healthcare company. What Happened : The transaction occurred on Monday, ...
Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon
Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in the world's largest standalone consumer healthcare firm, a bookrunner said on Tuesday.
Dr Reddy's completes acquisition of UK co Haleon's non-US nicotine replacement therapy biz
Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine replacement therapy (NRT) business for GBP 458 million. The deal includes b...
Pfizer to Pare Back Haleon Stake With 540 Million Share Offering
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant.
Pfizer to offload about 5.9% stake in UK's Haleon, says bookrunner
Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon , a bookrunner said on Monday.
Sensodyne maker Haleon to raise stake in China JV
British consumer healthcare company Haleon said on Friday it has agreed to raise its stake in its Chinese joint venture by 33% for 4.47 billion yuan ($637.35 million), taking its ownership to 88%.
20 'Every Day Stocks' I'd Struggle To Live Without
In this article, I go through a typical day and note 20 stocks whose revenue I contribute to, and would find it difficult not to. One motivation was to see how much of my budget at attention go into M...
Haleon Announces the Launch of Eroxon®, The First and Only FDA Cleared OTC Gel for Erectile Dysfunction, Available for U.S. Preorder Without a Prescription
Eroxon ® is Haleon's first offering in the sexual health space Clinical studies show Eroxon® is safe and effective in men with ED Eroxon® is available now for Amazon pre-order; available on shelves an...
Top 2 Risk Off Stocks That May Implode In August
As of Aug 9, 2024, two stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Haleon: Defensive Consumer Healthcare Stock As Safe Haven
Haleon is a consumer healthcare company formed from a GSK and Pfizer merger, with a 50% share price increase since trading began. Financial results show strong cash flows, with a net profit of 754M GB...
Haleon plc (HLN) Q2 2024 Earnings Call Transcript
Haleon plc (NYSE:HLN) Q2 2024 Earnings Call August 1, 2024 4:00 AM ET Company Participants Sonya Ghobrial - Investor Relations Brian McNamara - Chief Executive Officer Tobias Hestler - Chief Financia...